5 results about "Isopropylmalic acid" patented technology

The present disclosure relates to the field of bioengineered yeast strains as therapeutic platforms. In particular, engineered strains of yeast brassicae comprising a nucleic acid encoding a modified 3-isopropylmalate dehydrogenase (Leu2) and a therapeutic protein, and methods for treating or preventing a disease or condition in a subject in need thereof.

The application discloses tobacco isopropyl malate dehydrase NtIPDS, a coding gene, an RNAi interference carrier and application. The application successfully clones a coding gene of isopropyl malate dehydrase in tobacco, and the nucleotide sequence is as follows: (1) the nucleotide sequence shown in SEQ ID NO. 1; (2) the nucleotide sequence shown in SEQ ID NO. 1 is substituted and / or deleted and / or added with one or more nucleotides and the nucleotide sequence of the same functional protein. Based on the existing tobacco genetic engineering progress and related plant phenotype observation and identification, the NtIPDS gene is deeply researched, and it is found that the NtIPDS gene is related to tobacco chloroplast development and acyl sugar metabolism. After the gene is silenced, the chlorosis plant growth is slow, the chloroplast development is found to be abnormal through transmission electron microscope observation, and meanwhile, it is found that the acyl sugar content of the silenced plant is significantly increased through metabolic detection analysis.

The present disclosure relates to an isopropylmalate synthase variant and a method of producing L-leucine using the same.

The present application relates to: a novel mutant polypeptide having isopropylmalate synthase activity; and a method for producing L-leucine by using same. L-leucine can be produced at high yield by using the mutant polypeptide according to an embodiment.

This disclosure relates to the field of bioengineered yeast strains as therapeutic platforms. In particular, to genetically modified strains of Saccharomyces bouloidii yeast containing modified 3-isopropylmalate dehydrogenase (Leu2) and nucleic acids encoding therapeutic proteins, as well as methods for treating or preventing diseases or conditions in subjects requiring such treatment.